Evidence map›Paper›PMID 41172240›Full record

ArticleNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association2026

Kidney replacement therapy for men and women according to the ERA Registry and the USRDS.

Vianda S Stel, Nicholas C Chesnaye, Rianne Boenink, Brittany A Boerstra, Megan E Astley, Shona Methven, Line Heylen, Halima Resic, Marc A G J Ten Dam, Kristine Hommel and 18 more

Abstract readComparative Study
In one paragraph

Article in Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Vianda S StelERA Registry, Department of Medical Informatics, Amsterdam UMC - location University of Amsterdam, Amsterdam, The Netherlands.ORCID 0000-0002-0007-1947
Nicholas C ChesnayeERA Registry, Department of Medical Informatics, Amsterdam UMC - location University of Amsterdam, Amsterdam, The Netherlands.
Rianne BoeninkERA Registry, Department of Medical Informatics, Amsterdam UMC - location University of Amsterdam, Amsterdam, The Netherlands.
Brittany A BoerstraERA Registry, Department of Medical Informatics, Amsterdam UMC - location University of Amsterdam, Amsterdam, The Netherlands.ORCID 0000-0001-7820-0721
Megan E AstleyERA Registry, Department of Medical Informatics, Amsterdam UMC - location University of Amsterdam, Amsterdam, The Netherlands.
Shona MethvenScottish Renal Registry, Public Health Scotland, Edinburgh, Scotland.
Line HeylenDepartment of Nephrology, Ziekenhuis Oost-Limburg, Genk, Belgium.ORCID 0000-0002-4595-0195
Halima ResicSociety for Nephrology, Dialysis and Transplantation of Bosnia and Herzegovina, Sarajevo, Bosnia and Herzegovina.
Marc A G J Ten DamDutch Registry RENINE, Nefrovisie, Utrecht, The Netherlands.
Kristine HommelDepartment of Nephrology, Holbaek Hospital, Holbaek, Denmark.
Marit D SolbuSection of Nephrology, University Hospital of North Norway, Tromsø, Norway.
Maria F Slon RobleroHospital Universitario de Navarra, Pamplona, Spain.
Nuria Aresté-FosalbaNephrology Department, Virgen Macarena Hospital, Seville, Spain.
Danilo RadunovicClinical Center of Montenegro, Clinic for Nephrology, Podgorica, Montenegro.
Héctor García LópezTransplant Autonomic Coordination Department, Health Service of Castilla y León, Castilla y León, Spain.
Lukas BuchwinklerAustrian Dialysis and Transplantation Registry, Department of Internal Medicine IV (Nephrology and Hypertension), Medical University Innsbruck, Innsbruck, Austria.ORCID 0009-0009-3057-7306
Rebecca GuidottiInstitute of Nephrology, Stadtspital Zürich, Zürich, Switzerland.
Mathilde LassalleRenal Epidemiology and Information Network Registry, Paris, France.
Carmen SantiusteMurcia Renal Registry, Department of Epidemiology, Murcia Regional Health Council, IMIB-Arrixaca, Murcia, Spain.
Maria StendahlSwedish Renal Registry, Ryhov Regional Hospital, Jonkoping, Sweden.
Olafur S IndridasonSection of Nephrology, Landspitali University Hospital, Reykjavik, Iceland.
Almudena EscribáRegional Office for Transplant Coordination, Community of Madrid, Madrid, Spain.
María Encarnación Bouzas-CaamañoRegional Transplant Coordination of Galicia, Galician Health Service, Santiago de Compostela, Spain.
Olga Lucía Rodriguez ArévaloRegistry of Kidney Patients of the Valencian Community, General Directorate of Public Health, Ministry of Health, Valencia, Spain.
George MoustakasNephrology Department, General Hospital of Athens "G. Gennimatas", Athens, Greece.
Hermann Hernández VargasHospital San Pedro, LogroñoLa, Rioja, Spain.
Alberto OrtizDepartment of Nephrology and Hypertension, IIS-Fundacion Jimenez Diaz UAM, Madrid, Spain.ORCID 0000-0002-9805-9523
Anneke KramerERA Registry, Department of Medical Informatics, Amsterdam UMC - location University of Amsterdam, Amsterdam, The Netherlands.ORCID 0000-0002-7560-2669

Funding

European Renal Association
6 · The paper itself

Abstract

backgroundThis article compares the incidence and prevalence of kidney replacement therapy (KRT), kidney transplantation rates and mortality on KRT between Europe and the USA, including sex comparisons.

methodsData were derived for 2022 from the population-based European Renal Association (ERA) Registry and the United States Renal Data System (USRDS).

resultsIn 2022, the KRT incidence in the USA [388.7 per million population (pmp)] was 2.7-fold higher than in Europe (146.2 pmp), with a greater difference for women (3.2-fold) than for men (2.4-fold). The proportion of women initiating KRT was lower in Europe (35%) than in the USA (41%). Between 2013 and 2022, the KRT incidence in Europe was stable in women (+0.1% annually) but increased in men (+1.1%). In the USA, the KRT incidence increased similarly in women (+0.2%) and men (+0.3%). On 31 December 2022, the KRT prevalence was 2-fold (women 2.2-fold, men 1.9-fold) higher in the USA (2444.2 pmp) than in Europe (1218.6 pmp). The proportion of women was lower in Europe (38%) than in the USA (41%). The kidney transplantation rate was 1.7-fold higher in the USA (79.1 pmp) than in Europe (45.4 pmp), 1.9-fold for women and 1.7-fold for men, with women accounting for 37% of the recipients versus 39% in the USA. The KRT mortality rate was 1.5 times higher in the USA [145.0 per 1000 patient-years (py)] compared with Europe (100.5 per 1000 py): 1.6-fold for women and 1.4-fold for men. In Europe, mortality was lower for women receiving KRT (93.7 per 1000 py) than for men (104.6 per 1000 py), whereas in the USA the reverse was true (women 148.9 per 1000 py, men 142.2 per 1000 py).

conclusionThe US had a notably higher KRT incidence, prevalence, kidney transplantation rate and mortality compared with Europe. Differences between Europe and the USA were larger for women than for men.

Indexed as

Kidney Failure, ChronicKidney TransplantationRegistriesRenal Replacement TherapyAdultAgedEuropeFemaleFollow-Up StudiesHumansIncidenceMaleMiddle AgedPrevalencePrognosisSex Factorsepidemiologyincidencekidney replacement therapymortalityprevalence

Identifiers

PMID41172240
PMCPMC13270308

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.